Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Graham K. Cooper currently holds 50,000 shares of Orexigen Therapeutics, Inc. (OREX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Graham K. Cooper has been a net seller of OREX stock. They have purchased $0 and sold $5.7M worth of shares.
Graham K. Cooper's most recent insider trade was on Jun 20, 2024, when they sold 50,000 shares at $0.00 per share.
Graham K. Cooper serves as Executive at Orexigen Therapeutics, Inc. (OREX). They have executed 93 insider transactions totaling $5.7M over their tenure at the company.
Graham K. Cooper holds the position of Executive at Orexigen Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Graham K. Cooper has shown a selling trading pattern, with $0 in total purchases and $5.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Graham K. Cooper was on Sep 16, 2014, when they sold $3.1M worth of RCPT shares. This transaction involved 50,000 shares at $61.30 per share.
Graham K. Cooper currently owns 50,000 shares of Orexigen Therapeutics, Inc. (OREX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Graham K. Cooper's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Graham K. Cooper has 93 Form 4 filings on record as an insider at Orexigen Therapeutics, Inc..
Set alerts for Graham K. Cooper and 40,000+ other insiders.